Quinn Opportunity Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History

Quinn Opportunity Partners’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-53,847	Closed	-$946K	–	291
2021 Q3	$946K	Buy	+53,847	New	+$629K	0.06%	166

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Quinn Opportunity Partners's TRIL Position: Q4 2021 in Review

Quinn Opportunity Partners sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 53,847 shares — an estimated $946K sold.

Quinn Opportunity Partners first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $946K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Quinn Opportunity Partners reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Quinn Opportunity Partners sold 53,847 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $946K.
Quinn Opportunity Partners first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Quinn Opportunity Partners's Trillium Therapeutics Inc. position peaked at $946K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Quinn Opportunity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.